Impact of Vaginal Estrogen in the Treatment of Symptomatic Mild Pelvic Organ Prolapse With Pelvic Floor Physical Therapy
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Pelvic floor disorders
- Focus Therapeutic Use
- 27 Jan 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019, according to ClinicalTrials.gov record.
- 19 May 2015 Age limit revised from 40-60 years to 40-80 years.
- 19 May 2015 Planned End Date changed from 1 Jul 2013 to 1 Dec 2018, according to ClinicalTrials.gov record.